Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 9327136, 8 pages
https://doi.org/10.1155/2017/9327136
Research Article

High Neutrophil-to-Lymphocyte Ratio Predicts Cardiovascular Mortality in Chronic Hemodialysis Patients

1Department of Blood Purification, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
2Nephrology Faculty, Capital Medical University, Beijing, China

Correspondence should be addressed to Shixiang Wang; nc.ude.umcc@gnawxs

Received 27 October 2016; Revised 12 January 2017; Accepted 29 January 2017; Published 21 February 2017

Academic Editor: Giorgio Zauli

Copyright © 2017 Han Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Tonelli, S. A. Karumanchi, and R. Thadhani, “Epidemiology and mechanisms of uremia-related cardiovascular disease,” Circulation, vol. 133, no. 5, pp. 518–536, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Neirynck, G. Glorieux, E. Schepers, A. Dhondt, F. Verbeke, and R. Vanholder, “Pro-inflammatory cytokines and leukocyte oxidative burst in chronic kidney disease: culprits or innocent bystanders?” Nephrology Dialysis Transplantation, vol. 30, no. 6, pp. 943–951, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Yuksel, A. Yildiz, M. Oylumlu et al., “Novel markers of endothelial dysfunction and inflammation in Behçet’s disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio,” Clinical Rheumatology, vol. 35, no. 3, pp. 701–708, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Gong, S. Yang, X. Yang, and F. Guo, “Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer,” Clinics, vol. 71, no. 6, pp. 311–314, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kasuga, T. Kawahara, D. Takamoto et al., “Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer,” BMC Cancer, vol. 16, no. 1, article 396, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Nakamura, T. Nagasaka, T. Nishida et al., “Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer,” Oncology Letters, vol. 11, no. 6, pp. 3975–3981, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Uygur, H. Tanriverdi, Z. Aktop et al., “The neutrophil-to-lymphocyte ratio in patients with obstructive sleep apnoea syndrome and its relationship with cardiovascular disease,” Heart and Lung: Journal of Acute and Critical Care, vol. 45, no. 2, pp. 121–125, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Özpelit, B. Akdeniz, M. E. Özpelit et al., “Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension,” Journal of International Medical Research, vol. 43, no. 5, pp. 661–671, 2015. View at Publisher · View at Google Scholar
  9. B.-J. Kim, S.-H. Cho, K.-I. Cho, H.-S. Kim, J.-H. Heo, and T.-J. Cha, “The combined impact of neutrophil-to-lymphocyte ratio and type 2 diabetic mellitus on significant coronary artery disease and carotid artery atherosclerosis,” Journal of Cardiovascular Ultrasound, vol. 24, no. 2, pp. 115–122, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. K. I. Cho, S. H. Cho, A. Her, G. B. Singh, E. Shin, and Y. Taniyama, “Prognostic utility of neutrophil-to-lymphocyte ratio on adverse clinical outcomes in patients with severe calcific aortic stenosis,” PLoS ONE, vol. 11, no. 8, Article ID e0161530, 2016. View at Publisher · View at Google Scholar
  11. V. Isaac, C.-Y. Wu, C.-T. Huang, B. T. Baune, C.-L. Tseng, and C. S. McLachlan, “Elevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions,” Medicine, vol. 95, no. 23, Article ID e3832, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Erturk, H. A. Cakmak, O. Surgit et al., “The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease,” Journal of Cardiology, vol. 64, no. 5, pp. 371–376, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Ahbap, T. Sakaci, E. Kara et al., “Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in end-stage renal disease,” Clinical Nephrology, vol. 85, no. 4, pp. 199–208, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. X. An, H.-P. Mao, X. Wei et al., “Elevated neutrophil to lymphocyte ratio predicts overall and cardiovascular mortality in maintenance peritoneal dialysis patients,” International Urology and Nephrology, vol. 44, no. 5, pp. 1521–1528, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Ouellet, R. Malhotra, E. Lars Penne, L. Usvyat, N. W. Levin, and P. Kotanko, “Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients,” Clinical Nephrology, vol. 85, no. 4, pp. 191–198, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S.-J. Feng, H. Li, and S.-X. Wang, “Lower hydrogen sulfide is associated with cardiovascular mortality, which involves cPKCβII/Akt pathway in chronic hemodialysis patients,” Blood Purification, vol. 40, no. 3, pp. 260–269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Li, S.-J. Feng, G.-Z. Zhang, and S.-X. Wang, “Correlation of lower concentrations of hydrogen sulfide with atherosclerosis in chronic hemodialysis patients with diabetic nephropathy,” Blood Purification, vol. 38, no. 3-4, pp. 188–194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Stea, E. Bozec, S. Millasseau, H. Khettab, P. Boutouyrie, and S. Laurent, “Comparison of the complior analyse device with sphygmocor and complior SP for pulse wave velocity and central pressure assessment,” Journal of Hypertension, vol. 32, no. 4, pp. 873–880, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Gang and Z. Yanyan, “Increased neutrophil to lymphocyte ratio in persons suffering from hypertension with hyperhomocysteinemia,” Hypertension Research, vol. 39, no. 8, pp. 606–611, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. Ö. Cem, S. Yilmaz, A. Korkmaz, T. Fahrettin, I. Sahin, and V. Demir, “Evaluation of the neutrophil-lymphocyte ratio in newly diagnosed nondiabetic hypertensive patients with ascending aortic dilatation,” Blood Pressure Monitoring, vol. 21, no. 4, pp. 238–243, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Köklü, İ. Ö. Yüksel, Ş. Arslan et al., “Is elevated neutrophil-to-lymphocyte ratio a predictor of stroke in patients with intermediate carotid artery stenosis?” Journal of Stroke and Cerebrovascular Diseases, vol. 25, no. 3, pp. 578–584, 2016. View at Publisher · View at Google Scholar
  22. Z. Guo, S. Yu, L. Xiao et al., “Dynamic change of neutrophil to lymphocyte ratio and hemorrhagic transformation after thrombolysis in stroke,” Journal of Neuroinflammation, vol. 13, no. 1, article 199, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Sheng, B. Chen, M. He, M. Zhang, and G. Shen, “Neutrophil to lymphocyte ratio is related to electrocardiographic sign of spontaneous reperfusion in patients with ST-segment elevation myocardial infarction,” Archives of Medical Research, vol. 47, no. 3, pp. 180–185, 2016. View at Publisher · View at Google Scholar
  24. M. Verdoia, A. Schaffer, L. Barbieri et al., “Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation,” Netherlands Heart Journal, vol. 24, no. 7-8, pp. 462–474, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Martínez-Urbistondo, A. Beltrán, O. Beloqui, and A. Huerta, “The neutrophil–lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects,” Nefrología, vol. 36, no. 4, pp. 397–403, 2016. View at Publisher · View at Google Scholar
  26. J. L. Davis, V. Moutinho, K. S. Panageas, and D. G. Coit, “A peripheral blood biomarker estimates probability of survival: the neutrophil–lymphocyte ratio in noncancer patients,” Biomarkers in Medicine, vol. 10, no. 9, pp. 953–957, 2016. View at Publisher · View at Google Scholar
  27. J. A. González-Fajardo, J. A. Brizuela-Sanz, B. Aguirre-Gervás et al., “Prognostic significance of an elevated neutrophil-lymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia,” Annals of Vascular Surgery, vol. 28, no. 4, pp. 999–1004, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. V. A. Benites-Zapata, A. V. Hernandez, V. Nagarajan, C. A. Cauthen, R. C. Starling, and W. H. Wilson Tang, “Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure,” American Journal of Cardiology, vol. 115, no. 1, pp. 57–61, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. E. Durmus, T. Kivrak, F. Gerin, M. Sunbul, I. Sari, and O. Erdogan, “Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are predictors of heart failure,” Arquivos Brasileiros de Cardiologia, vol. 105, no. 6, pp. 606–613, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. E. Tatar, C. Mirili, T. Isikyakar et al., “The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease,” Acta Clinica Belgica, vol. 71, no. 4, pp. 221–226, 2016. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Kocyigit, E. Eroglu, A. Unal et al., “Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease,” Journal of Nephrology, vol. 26, no. 2, pp. 358–365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Solak, M. I. Yilmaz, A. Sonmez et al., “Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease,” Clinical and Experimental Nephrology, vol. 17, no. 4, pp. 532–540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Çankaya, Y. Bilen, M. Keles, A. Uyanik, N. Bilen, and B. Aydinli, “Neutrophil-lymphocyte ratio is significantly decreased in preemptive renal transplant patients,” Transplantation Proceedings, vol. 47, no. 5, pp. 1364–1368, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. L. E. Cahill, M. L. Bertoia, S. A. Aroner, K. J. Mukamal, and M. K. Jensen, “New and emerging biomarkers in cardiovascular disease,” Current Diabetes Reports, vol. 15, no. 11, article 88, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. W. Koenig, “High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy,” International Journal of Cardiology, vol. 168, no. 6, pp. 5126–5134, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. N. G. Kounis, G. D. Soufras, G. Tsigkas, and G. Hahalis, “White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease,” Clinical and Applied Thrombosis/Hemostasis, vol. 21, no. 2, pp. 139–143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. M. E. Afari and T. Bhat, “Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update,” Expert Review of Cardiovascular Therapy, vol. 14, no. 5, pp. 573–577, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Korabecna and V. Tesar, “NETosis provides the link between activation of neutrophils on hemodialysis membrane and comorbidities in dialyzed patients,” Inflammation Research, pp. 1–10, 2016. View at Publisher · View at Google Scholar
  40. D. Dąbrowska, E. Jabłońska, M. Garley, W. Ratajczak-Wrona, and A. Iwaniuk, “New aspects of the biology of neutrophil extracellular traps,” Scandinavian Journal of Immunology, vol. 84, no. 6, pp. 317–322, 2016. View at Publisher · View at Google Scholar
  41. D. Tovbin, V. Novack, M. P. Wiessman, A. A. Elkadir, M. Zlotnik, and A. Douvdevani, “Circulating cell-free DNA in hemodialysis patients predicts mortality,” Nephrology Dialysis Transplantation, vol. 27, no. 10, pp. 3929–3935, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Atamaniuk, C. Kopecky, S. Skoupy, M. D. Säemann, and T. Weichhart, “Apoptotic cell-free DNA promotes inflammation in haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 27, no. 3, pp. 902–905, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Qin, S. Fu, C. Speake, C. J. Greenbaum, and J. M. Odegard, “NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count,” Clinical and Experimental Immunology, vol. 184, no. 3, pp. 318–322, 2016. View at Publisher · View at Google Scholar · View at Scopus